Partner Profile

We develop quantitative modells of signal transduction and gene regulation, with a focus on signalling in colon cancer. We use organoids, mass-cytometry, scRNA-seq to generate perturbation data on a single cell level, and generate models that allow us to quantitatively dissect the response of complex signalling in heterogenious tissues on perturbations by oncogenic mutations and/or drugs.